Cargando…
The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study
PURPOSE: Accumulated studies revealed that electromagnetic field can affect human brain and sleep, and the extremely low-frequency electromagnetic field, Schumann resonance, may have the potential to reduce insomnia symptoms. The purpose of this study was to investigate the responses of patients wit...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189153/ https://www.ncbi.nlm.nih.gov/pubmed/35707548 http://dx.doi.org/10.2147/NSS.S346941 |
_version_ | 1784725521620271104 |
---|---|
author | Huang, Yu-Shu Tang, I Chin, Wei-Chih Jang, Ling-Sheng Lee, Chin-Pang Lin, Chen Yang, Chun-Pai Cho, Shu-Ling |
author_facet | Huang, Yu-Shu Tang, I Chin, Wei-Chih Jang, Ling-Sheng Lee, Chin-Pang Lin, Chen Yang, Chun-Pai Cho, Shu-Ling |
author_sort | Huang, Yu-Shu |
collection | PubMed |
description | PURPOSE: Accumulated studies revealed that electromagnetic field can affect human brain and sleep, and the extremely low-frequency electromagnetic field, Schumann resonance, may have the potential to reduce insomnia symptoms. The purpose of this study was to investigate the responses of patients with insomnia to a non-invasive treatment, Schumann resonance (SR), and to evaluate its effectiveness by subjective and objective sleep assessments. PATIENTS AND METHODS: We adopted a double-blinded and randomized design and 40 participants (70% female; 50.00 ± 13.38 year) with insomnia completed the entire study. These participants were divided into the SR-sleep-device group and the placebo-device group and were followed up for four weeks. The study used polysomnography (PSG) to measure objective sleep and used sleep diaries, Pittsburgh Sleep Quality Inventory (PSQI), Epworth Sleepiness Scale (ESS), and visual analogy of sleep satisfaction to measure subjective sleep. The 36-Item Short-Form Health Survey (SF-36) was used to evaluate quality of life. Chi-square test, Mann–Whitney U-test, and Wilcoxon test were used to analyze the data. RESULTS: About 70% of the subjects were women, with an average age of 50±13.38 years and an average history of insomnia of 9.68±8.86 years. We found that in the SR-sleep-device group, objective sleep measurements (sleep-onset-latency, SOL, and total-sleep-time, TST) and subjective sleep questionnaires (SOL, TST, sleep-efficiency, sleep-quality, daytime-sleepiness, and sleep-satisfaction) were significantly improved after using the SR-sleep-device; in the placebo-device group, only such subjective sleep improvements as PSQI and sleep-satisfaction were observed. CONCLUSION: This study demonstrates that the SR-sleep-device can reduce the insomnia symptoms through both objective and subjective tests, with minimal adverse effects. Future studies can explore the possible mechanism of SR and health effects and, with a longer tracking time, verify the effectiveness and side effects. |
format | Online Article Text |
id | pubmed-9189153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-91891532022-06-14 The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study Huang, Yu-Shu Tang, I Chin, Wei-Chih Jang, Ling-Sheng Lee, Chin-Pang Lin, Chen Yang, Chun-Pai Cho, Shu-Ling Nat Sci Sleep Original Research PURPOSE: Accumulated studies revealed that electromagnetic field can affect human brain and sleep, and the extremely low-frequency electromagnetic field, Schumann resonance, may have the potential to reduce insomnia symptoms. The purpose of this study was to investigate the responses of patients with insomnia to a non-invasive treatment, Schumann resonance (SR), and to evaluate its effectiveness by subjective and objective sleep assessments. PATIENTS AND METHODS: We adopted a double-blinded and randomized design and 40 participants (70% female; 50.00 ± 13.38 year) with insomnia completed the entire study. These participants were divided into the SR-sleep-device group and the placebo-device group and were followed up for four weeks. The study used polysomnography (PSG) to measure objective sleep and used sleep diaries, Pittsburgh Sleep Quality Inventory (PSQI), Epworth Sleepiness Scale (ESS), and visual analogy of sleep satisfaction to measure subjective sleep. The 36-Item Short-Form Health Survey (SF-36) was used to evaluate quality of life. Chi-square test, Mann–Whitney U-test, and Wilcoxon test were used to analyze the data. RESULTS: About 70% of the subjects were women, with an average age of 50±13.38 years and an average history of insomnia of 9.68±8.86 years. We found that in the SR-sleep-device group, objective sleep measurements (sleep-onset-latency, SOL, and total-sleep-time, TST) and subjective sleep questionnaires (SOL, TST, sleep-efficiency, sleep-quality, daytime-sleepiness, and sleep-satisfaction) were significantly improved after using the SR-sleep-device; in the placebo-device group, only such subjective sleep improvements as PSQI and sleep-satisfaction were observed. CONCLUSION: This study demonstrates that the SR-sleep-device can reduce the insomnia symptoms through both objective and subjective tests, with minimal adverse effects. Future studies can explore the possible mechanism of SR and health effects and, with a longer tracking time, verify the effectiveness and side effects. Dove 2022-06-08 /pmc/articles/PMC9189153/ /pubmed/35707548 http://dx.doi.org/10.2147/NSS.S346941 Text en © 2022 Huang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Huang, Yu-Shu Tang, I Chin, Wei-Chih Jang, Ling-Sheng Lee, Chin-Pang Lin, Chen Yang, Chun-Pai Cho, Shu-Ling The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study |
title | The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study |
title_full | The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study |
title_fullStr | The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study |
title_full_unstemmed | The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study |
title_short | The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study |
title_sort | subjective and objective improvement of non-invasive treatment of schumann resonance in insomnia—a randomized and double-blinded study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189153/ https://www.ncbi.nlm.nih.gov/pubmed/35707548 http://dx.doi.org/10.2147/NSS.S346941 |
work_keys_str_mv | AT huangyushu thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT tangi thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT chinweichih thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT janglingsheng thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT leechinpang thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT linchen thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT yangchunpai thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT choshuling thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT huangyushu subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT tangi subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT chinweichih subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT janglingsheng subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT leechinpang subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT linchen subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT yangchunpai subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy AT choshuling subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy |